NewsFeed
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Alberto Sifuentes Giraldo: Innovative CAR–T Cell Therapy Promises SLE Remission and Fertility
Feb 27, 2026, 13:45

Alberto Sifuentes Giraldo: Innovative CAR–T Cell Therapy Promises SLE Remission and Fertility

Alberto Sifuentes Giraldo, Rheumatologist, Medical Doctor at National University of San Marcos, shared a post on LinkedIn:

“BCMA/CD19 dual-target CAR–T cell therapy can induce long-term systemic lupus erythematosus (SLE) remission, preserve fertility, and enable successful, healthy pregnancies/neonatal outcomes, as evidenced by the interesting case of a 24-year-old female patient with refractory class IV lupus nephritis who received this therapy and achieved sustained molecular remission (>30 months) with no flares:

  • She had two spontaneous pregnancies (conceiving at 6 and 21 months post-infusion), resulting in term vaginal deliveries of healthy female infants.
  • No CAR–T cell DNA was detected in maternal blood, breast milk, placenta, or infants’ blood (at birth and follow-up), confirming no vertical transmission.
  • Both infants showed normal growth, neurodevelopment, and immune function during follow-up.

The patient’s quality of life markedly improved post-therapy.

This appears to represent one of the first detailed reports addressing fertility and pregnancy safety in the context of this emerging treatment for SLE, highlighting the need for pregnancy-related guidelines in post-CAR–T autoimmune patients.

Jiang Q, Wang M, Wang M, Zhou J, Zheng K, Ding L, Hong M. Successful spontaneous pregnancies and healthy neonates after dual-target CAR–T cell therapy in systemic lupus erythematosus. Arthritis Rheumatol, 2026.”

Title: Successful Spontaneous Pregnancies and Healthy Neonates After Dual-Target CAR–T Cell Therapy in Systemic Lupus Erythematosus

Authors: Qinglian Jiang, Mingxia Wang, Ming Wang, Jiajun Zhou, Kaijun Zheng, Ling Ding, Ming Hong

Read the full article.

Alberto Sifuentes Giraldo: Innovative CAR–T Cell Therapy Promises SLE Remission and Fertility